menu

Hydatid Disease Treatment Market

Schedule Call

Hydatid Disease Treatment Market

Hydatid Disease Treatment Market by Drug (Mebendazole, Albendazole), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

GR - 428620 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: July 03, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023-2031


Hydatid Disease Treatment Market Scope

Report Attribute

Details

CAGR

2.3%

Base Year for Estimation

2022

Forecast Period

2023 to 2031

Historical Year

2021

Segments Covered

Drug, Distribution Channel, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global hydatid disease treatment market is expected to register a revenue CAGR of 2.3% from 2023 to 2031.

Hydatid Disease Treatment Market Fundamentals

Hydatid disease, or echinococcosis, is a parasitic infection caused by the larvae of the Echinococcus granulosus or Echinococcus multilocularis tapeworms. It primarily affects the liver and lungs but can also involve other organs, such as the brain and spleen. The treatment of hydatid disease typically involves a combination of surgical intervention and medication.

The drug treatment for hydatid disease primarily involves the use of anthelmintic medications. The two main drugs used to treat hydatid disease are albendazole and mebendazole. These drugs belong to the benzimidazole class and are effective against the larval stages of Echinococcus granulosus and Echinococcus multilocularis, the parasites responsible for causing hydatid disease.

Hydatid Disease Treatment Market Dynamics

Hydatid disease is a significant public health concern in many regions worldwide, especially in rural areas where livestock farming is prevalent. The high prevalence and incidence of the disease create a demand for effective treatment options, thus boosting the global hydatid disease treatment market. For instance, according to the WHO factsheet of May 2021, human incidence rates for cystic echinococcosis can exceed 50 per 100,000 person-years in endemic areas, with prevalence levels as high as 5%-10% in Argentina, Peru, East Africa, Central Asia, and China. Increased awareness about hydatid disease and improved diagnostic techniques contribute to early detection and prompt treatment. As diagnostic capabilities improve, more cases are diagnosed, increasing the demand for treatment options.

Furthermore, the availability of effective medications for treating hydatid disease, such as albendazole, plays a crucial role in managing the infection. Ongoing research and development efforts to discover new drugs or improve existing ones contribute to the growth of the treatment market. Moreover, collaborations between countries, international organizations, and research institutions facilitate the exchange of knowledge and resources, leading to improved treatment strategies for hydatid disease. These collaborations promote diagnosis, surgery, and medication advancements, further driving the global hydatid disease treatment market. 

However, treating hydatid disease, particularly surgical interventions and long-term medication, can be costly. The expenses associated with surgery, hospitalization, medications, and follow-up care can burden patients and healthcare systems financially. The high cost of treatment may limit its accessibility, especially in low-income regions or areas with inadequate healthcare coverage. Furthermore, many regions may have limited access to healthcare facilities and specialized treatment centers, especially in rural and underserved areas. This lack of access can hinder the timely diagnosis and appropriate treatment of hydatid disease, thereby impacting the growth of the treatment market. Additionally, the high cost of treatment and limited access to healthcare in developing nations are some of the restraints impeding the overall market growth. 

Hydatid Disease Treatment Market Ecosystem

The global hydatid disease treatment market has been analyzed from the following perspectives: by the drug, distribution channel, and region.

Hydatid Disease Treatment Market by Drug 

Based on the drug, the global hydatid disease treatment market is segmented into albendazole, praziquantel, and mebendazole.

The albendazole segment dominated the market with the principal revenue share in 2022. Albendazole is a broad-spectrum anthelmintic drug commonly used to treat various parasitic infections, including hydatid disease. It belongs to the benzimidazole class of drugs and has demonstrated efficacy against the larval stages of Echinococcus granulosus and Echinococcus multilocularis, the parasites responsible for causing hydatid disease. Albendazole exerts its anthelmintic activity by interfering with the microtubule structure of the parasites. It inhibits the polymerization of tubulin, a protein essential for the formation of microtubules, leading to disruption of cellular transport and various metabolic processes in the parasite. This ultimately results in the death of the parasite. Albendazole is generally administered orally as a tablet or suspension. The dosage is determined based on body weight, age, and the specific parasitic infection being treated. It is important to follow the prescribed dosage and duration of treatment as directed by the healthcare provider. These aspects contribute to the growth of the albendazole segment.

The mebendazole segment is a key player in the hydatid disease treatment market, with the largest revenue share in 2022. Mebendazole is an anthelmintic medication that belongs to the benzimidazole class of drugs. While albendazole is more commonly used to treat hydatid disease, mebendazole can be an alternative treatment option. Mebendazole works by inhibiting the formation of microtubules in the parasites, including Echinococcus granulosus and Echinococcus multilocularis, responsible for causing hydatid disease. It disrupts the parasites' cellular structures and functions, leading to their death. Mebendazole can be used as an alternative or adjunctive treatment to albendazole in managing hydatid disease. While albendazole is the preferred choice due to its broader spectrum of activity and better absorption, mebendazole may be considered when it is unavailable or contraindicated. These overall factors contribute to the growth of the mebendazole segment. 

Hydatid Disease Treatment Market by Distribution Channel

Based on the distribution channel, the global hydatid disease treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

The hospital pharmacies segment is a key player in the hydatid disease treatment market, with the largest revenue share in 2022. Hospital pharmacies play a significant role in the treatment market for hydatid disease by providing medications, including anthelmintics like albendazole, to patients and healthcare providers involved in managing the disease. Hospital pharmacies are responsible for dispensing medications prescribed for hydatid disease treatment. This includes albendazole and other drugs used to manage the infection. Pharmacists ensure the accurate dispensing of prescribed medications, provide information on proper medication administration, and address patients’ concerns or questions. Hospital pharmacies are responsible for procuring the necessary medications to treat hydatid disease. This involves maintaining adequate stock levels of anthelmintic drugs like albendazole to meet the demands of patients and healthcare providers. Pharmacists collaborate with suppliers and wholesalers to ensure a consistent supply of medications. Hospital pharmacists provide drug information and education to patients and healthcare professionals involved in the treatment of hydatid disease. They explain the proper use, dosage, and potential side effects of medications like albendazole. Pharmacists also offer guidance on adherence to treatment regimens, potential drug interactions, and other important considerations. These overall factors contribute to the growth of the hospital pharmacies segment. 

The online pharmacies segment is expected to be the fastest-growing segment throughout the forecast period, owing to the convenience of getting medicine at the doorstep. Online pharmacies, also known as internet pharmacies or e-pharmacies, are virtual platforms that enable individuals to purchase medications and healthcare products online. In the hydatid disease treatment market, online pharmacies can provide convenient access to medications, including those used to manage the disease. Online pharmacies offer a wide range of medications, including anthelmintics like albendazole, commonly used to treat hydatid disease. These pharmacies typically have a comprehensive inventory of medications, allowing patients to easily access the necessary drugs for their treatment. Online pharmacies provide a convenient option for individuals seeking medications for hydatid disease treatment. They offer the convenience of 24/7 access, allowing patients to browse and purchase medications from the comfort of their own homes. This can be particularly beneficial for patients living in remote areas or those with limited mobility. These overall factors contribute to the growth of the online pharmacies segment. 

Hydatid Disease Treatment Market by Region

Geographically, the global hydatid disease treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominated the global hydatid disease treatment market with the largest revenue share in 2022, attributed to a well-developed healthcare infrastructure, including advanced medical facilities, hospitals, and specialized centers. These facilities provide the necessary resources and expertise for diagnosing, treating, and managing hydatid disease. Additionally, regional companies are continuously involved in partnerships, mergers, and acquisitions, which are also expected to improve the hydatid disease treatment market outlook. North America is a hub for medical research and innovation. Ongoing research focuses on improving diagnostic methods, treatment strategies, and outcomes for hydatid disease. Collaborative studies, clinical trials, and advancements in imaging techniques contribute to developing more effective and targeted treatment approaches.

Hydatid Disease Treatment Market Competitive Landscape

The prominent players operating in the global hydatid disease treatment market are:

Hydatid Disease Treatment Market Strategic Developments

  • In April 2021, Dr. Reddy's Laboratories and its subsidiaries announced the release of Albendazole Tablets, USP, a therapeutic comparable generic version of Albenza Tablets approved by the United States Food and Drug Administration (USFDA).

Frequently Asked Questions About This Report

Hydatid disease, also known as echinococcosis, is a parasitic infection caused by the larvae of the Echinococcus granulosus or Echinococcus multilocularis tapeworms.

The revenue CAGR of the hydatid disease treatment market during the forecast period will be 2.3% from 2023 to 2031.

Some key global hydatid disease treatment companies are Janssen Global Services, LLC (Johnson & Johnson Services Inc.), Lupin Limited, Cadila Pharmaceuticals Limited, Zydus Group, Mankind Pharma, and Ipca Laboratories Ltd.

The limited access to healthcare and the high cost of treatment are factors restricting the global market growth.

The rising drug development activities, technological advancements, and collaboration between market players drive market growth.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL HYDATID DISEASE TREATMENT MARKET- ANALYSIS & FORECAST, BY DRUG
    1. Albendazole
    2. Praziquantel
    3. Mebendazole
  6. GLOBAL HYDATID DISEASE TREATMENT MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospital Pharmacies
    2. Retail Pharmacies 
    3. Online Pharmacies
  7. GLOBAL HYDATID DISEASE TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Hydatid Disease Treatment Market
      1. North America Hydatid Disease Treatment Market, by Drug 
      2. North America Hydatid Disease Treatment Market, by Distribution Channel
      3. North America Hydatid Disease Treatment Market, by Country
        1. U.S.
          1. U.S. Hydatid Disease Treatment Market, by Drug 
          2. U.S. Hydatid Disease Treatment Market, by Distribution Channel
        2. Canada
          1. Canada Hydatid Disease Treatment Market, by Drug 
          2. Canada Hydatid Disease Treatment Market, by Distribution Channel
    2. Europe Hydatid Disease Treatment Market
      1. Europe Hydatid Disease Treatment Market, by Drug 
      2. Europe Hydatid Disease Treatment Market, by Distribution Channel 
      3. Europe Hydatid Disease Treatment Market, by Country/Region
        1. Germany
          1. Germany Hydatid Disease Treatment Market, by Drug 
          2. Germany Hydatid Disease Treatment Market, by Distribution Channel
        2. U.K.
          1. U.K. Hydatid Disease Treatment Market, by Drug
          2. U.K. Hydatid Disease Treatment Market, by Distribution Channel
        3. France
          1. France Hydatid Disease Treatment Market, by Drug 
          2. France Hydatid Disease Treatment Market, by Distribution Channel
        4. Spain
          1. Spain Hydatid Disease Treatment Market, by Drug 
          2. Spain Hydatid Disease Treatment Market, by Distribution Channel
        5. Italy
          1. Italy Hydatid Disease Treatment Market, by Drug 
          2. Italy Hydatid Disease Treatment Market, by Distribution Channel
        6. Rest of Europe 
          1. Rest of Europe Hydatid Disease Treatment Market, by Drug 
          2. Rest of Europe Hydatid Disease Treatment Market, by Distribution Channel
    3. Asia Pacific Hydatid Disease Treatment Market
      1. Asia Pacific Hydatid Disease Treatment Market, by Drug 
      2. Asia Pacific Hydatid Disease Treatment Market, by Distribution Channel
      3. Asia Pacific Hydatid Disease Treatment Market, by Country/Region
        1. China
          1. China Hydatid Disease Treatment Market, by Drug 
          2. China Hydatid Disease Treatment Market, by Distribution Channel
        2. Japan
          1. Japan Hydatid Disease Treatment Market, by Drug 
          2. Japan Hydatid Disease Treatment Market, by Distribution Channel 
        3. India
          1. India Hydatid Disease Treatment Market, by Drug 
          2. India Hydatid Disease Treatment Market, by Distribution Channel
        4. South Korea
          1. South Korea Hydatid Disease Treatment Market, by Drug 
          2. South Korea Hydatid Disease Treatment Market, by Distribution Channel
        5. Australia
          1. Australia Hydatid Disease Treatment Market, by Drug 
          2. Australia Hydatid Disease Treatment Market, by Distribution Channel
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Hydatid Disease Treatment Market, by Drug 
          2. Rest of Asia Pacific Hydatid Disease Treatment Market, by Distribution Channel
    4. Latin America Hydatid Disease Treatment Market
      1. Latin America Hydatid Disease Treatment Market, by Drug 
      2. Latin America Hydatid Disease Treatment Market, by Distribution Channel
      3. Latin America Hydatid Disease Treatment Market, by Country/ Region
        1. Brazil
          1. Brazil Hydatid Disease Treatment Market, by Drug 
          2. Brazil Hydatid Disease Treatment Market, by Distribution Channel
        2. Mexico
          1. Mexico Hydatid Disease Treatment Market, by Drug 
          2. Mexico Hydatid Disease Treatment Market, by Distribution Channel 
        3. Argentina
          1. Argentina Hydatid Disease Treatment Market, by Drug 
          2. Argentina Hydatid Disease Treatment Market, by Distribution Channel
        4. Rest of Latin America
          1. Rest of Latin America Hydatid Disease Treatment Market, by Drug 
          2. Rest of Latin America Hydatid Disease Treatment Market, by Distribution Channel 
    5. Middle East & Africa Hydatid Disease Treatment Market
      1. Middle East & Africa Hydatid Disease Treatment Market, by Drug 
      2. Middle East & Africa Hydatid Disease Treatment Market, by Distribution Channel
      3. Middle East & Africa Hydatid Disease Treatment Market, by Country/ Region
        1. GCC Countries
          1. GCC Countries Hydatid Disease Treatment Market, by Drug 
          2. GCC Countries Hydatid Disease Treatment Market, by Distribution Channel
        2. South Africa
          1. South Africa Hydatid Disease Treatment Market, by Drug 
          2. South Africa Hydatid Disease Treatment Market, by Distribution Channel 
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Hydatid Disease Treatment Market, by Drug 
          2. Rest of Middle East & Africa Hydatid Disease Treatment Market, by Distribution Channel
  8. COMPANY PROFILES         
    1. Amneal Pharmaceuticals LLC
      1. Business Snapshot 
      2. Products Offered
      3. Financial Details
      4. Strategic Development
    2. GSK plc
    3. Abbott Laboratories Inc.
    4. Merck KGaA
    5. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
    6. Lupin Limited
    7. Cadila Pharmaceuticals Limited
    8. Zydus Group
    9. Mankind Pharma
    10. Ipca Laboratories Ltd.

*Insights on financial performance are subject to the availability of information in the public domain

 

List of Tables

 

  1. Global Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million)
  2. Global Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  3. Global Hydatid Disease Treatment Market, by Region, 2021-2031 (US$ Million) 
  4. North America Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  5. North America Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  6. North America Hydatid Disease Treatment Market, by Country, 2021-2031 (US$ Million) 
  7. U.S. Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  8. U.S. Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  9. Canada Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  10. Canada Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  11. Europe Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  12. Europe Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  13. Europe Hydatid Disease Treatment Market, by Country/ Region, 2021-2031 (US$ Million) 
  14. Germany Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  15. Germany Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  16. U.K. Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  17. U.K. Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  18. France Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  19. France Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  20. Italy Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  21. Italy Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  22. Spain Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  23. Spain Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  24. Rest of Europe Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  25. Rest of Europe Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  26. Asia Pacific Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  27. Asia Pacific Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  28. Asia Pacific Hydatid Disease Treatment Market, by Country/ Region, 2021-2031 (US$ Million) 
  29. China Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  30. China Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  31. Japan Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  32. Japan Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  33. India Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  34. India Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  35. South Korea Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  36. South Korea Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  37. Australia Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  38. Australia Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  39. Rest of Asia Pacific Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  40. Rest of Asia Pacific Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  41. Latin America Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  42. Latin America Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  43. Latin America Hydatid Disease Treatment Market, by Country/ Region, 2021–2031 (US$ Million)
  44. Brazil Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  45. Brazil Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  46. Mexico Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  47. Mexico Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  48. Argentina Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  49. Argentina Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  50. Rest of Latin America Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  51. Rest of Latin America Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  52. Middle East and Africa Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  53. Middle East and Africa Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  54. Middle East and Africa Hydatid Disease Treatment Market, by Country/ Region, 2021–2031 (US$ Million)
  55. GCC Countries Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  56. GCC Countries Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  57. South Africa Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  58. South Africa Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  59. Rest of Middle East & Africa Hydatid Disease Treatment Market, by Drug, 2021-2031 (US$ Million) 
  60. Rest of Middle East & Africa Hydatid Disease Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 

 

List of Figures

 

  1. Hydatid Disease Treatment Market Ecosystem  
  2. Snapshot of Global Hydatid Disease Treatment Market, 2021 & 2031 
  3. Snapshot of Global Hydatid Disease Treatment Market, by Region, 2021 & 2031 
  4. Global Hydatid Disease Treatment Market: COVID-19 Pandemic Impact Assessment 
  5. Global Hydatid Disease Treatment Market: Key Players & Competitive Positioning (2022) 
  6. Hydatid Disease Treatment: Market Dynamics 
  7. Global Hydatid Disease Treatment Market for Albendazole, 2021-2031 (US$ Million)
  8. Global Hydatid Disease Treatment Market for Praziquantel, 2021-2031 (US$ Million)
  9. Global Hydatid Disease Treatment Market for Mebendazole, 2021-2031 (US$ Million)
  10. Global Hydatid Disease Treatment Market for Hospital Pharmacies, 2021-2031 (US$ Million)
  11. Global Hydatid Disease Treatment Market for Retail Pharmacies, 2021-2031 (US$ Million)
  12. Global Hydatid Disease Treatment Market for Online Pharmacies, 2021-2031 (US$ Million)
  13. North America Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  14. U.S. Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  15. Canada Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  16. Europe Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  17. Germany Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  18. U.K. Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  19. France Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  20. Italy Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  21. Spain Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  22. Rest of Europe Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  23. Asia Pacific Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  24. China Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  25. Japan Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  26. India Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  27. South Korea Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  28. Australia Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  29. Rest of Asia Pacific Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  30. Latin America Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  31. Brazil Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  32. Mexico Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  33. Argentina Hydatid Disease Treatment Market, 2021-2031 (US$ Million)
  34. Rest of Latin America Hydatid Disease Treatment Market, 2021-2031 (US$ Million)
  35. Middle East & Africa Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  36. GCC Countries Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  37. South Africa Hydatid Disease Treatment Market, 2021-2031 (US$ Million) 
  38. Rest of Middle East & Africa Hydatid Disease Treatment Market, 2021-2031 (US$ Million)
  39. Amneal Pharmaceuticals LLC Revenue from 2019 Onwards (US$ Million)
  40. GSK plc Revenue from 2019 Onwards (US$ Million)
  41. Abbott Laboratories Inc. Revenue from 2019 Onwards (US$ Million)
  42. Merck KGaA Revenue from 2019 Onwards (US$ Million)
  43. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.) Revenue from 2019 Onwards (US$ Million)
  44. Lupin Limited Revenue from 2019 Onwards (US$ Million)
  45. Cadila Pharmaceuticals Limited Revenue from 2019 Onwards (US$ Million)
  46. Zydus Group Revenue from 2019 Onwards (US$ Million)
  47. Mankind Pharma Revenue from 2019 Onwards (US$ Million)
  48. Ipca Laboratories Ltd. Revenue from 2019 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Hydatid Disease Treatment Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Hydatid Disease Treatment Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports